Webinar: T Cells: A New Hope for Lasting Protection against SARS-CoV-2
Many immunologists are looking at T cells to understand the potential for lasting immunity to SARS-CoV-2. In this webinar, Drs. Alessandro Sette and Shane Crotty of La Jolla Institute for Immunology present their latest findings in T cell function following SARS-CoV-2 infection and the implications for vaccine development and lasting immune memory.
Topics covered:
1. CD4+ and CD8+ T cell recognition of SARS-CoV-2 sequences in unexposed individuals and potential cross-reactivity with common cold coronaviruses
2. Implications of the T cell response against SARS-CoV-2 for vaccine design and viral escape
3. How the nature of the acute immune response correlates with COVID-19 severity
4. Factors affecting COVID-19 immune response duration and memory
Видео Webinar: T Cells: A New Hope for Lasting Protection against SARS-CoV-2 канала BioLegend
Topics covered:
1. CD4+ and CD8+ T cell recognition of SARS-CoV-2 sequences in unexposed individuals and potential cross-reactivity with common cold coronaviruses
2. Implications of the T cell response against SARS-CoV-2 for vaccine design and viral escape
3. How the nature of the acute immune response correlates with COVID-19 severity
4. Factors affecting COVID-19 immune response duration and memory
Видео Webinar: T Cells: A New Hope for Lasting Protection against SARS-CoV-2 канала BioLegend
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Arlene Sharpe: "Immunology: T cells" (11/3/2020)COVID and the ACE-2 surface proteinCOVID-19 Pandemic Update 101: T Cell Immunity vs. Antibodies & Prior Exposure to Other CoronavirusesPerspectives on the Pandemic | "Blood Clots and Beyond" | Episode 15Surface and Intracellular Cytokine Staining for Flow CytometrySARS-CoV-2 Variants | UK + South African + Brazil VariantsI tested positive for SARS-CoV-2Ce3D™ Tissue Clearing Kit Staining Protocol for MicroscopyDiagnosis, Treatment and Immunopathogenesis of Chronic COVID-19 (PASC)Lesson Learned from COVID-19 and HIV/AIDS Pandemics with Richard D'Aquila, MDUsing TotalSeq™ Antibodies for CITE-SeqCheckpoint Molecules Q&A with Dr. Vijay KuchrooThe T-cells are not alright - an interview with Dr. Anthony Leonardi, T-cell researcherJohnson and Johnson Vaccine Pause: A Rare Blood Clot Called Cerebral Venous Sinus Thrombosis (CVST)T Cells: A New Hope for Lasting Protection against SARS-CoV-2Mini ELISA Plate Reader™ and Software TutorialT Cells: A New Hope for Lasting Protection Against SARS-CoV-2Immune responses after dengue virus infection: friend or foe? by Dr. Tineke CantaertDelta Variant Versus Previous COVID 19 Infection vs. Vaccines (Coronavirus Update 131)Delta Variant: Top 10 COVID Questions and How to Prepare